<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24890" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Headache From Medication Overuse</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aleksenko</surname>
            <given-names>Dmitri</given-names>
          </name>
          <aff>Louisiana State University HSC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Maini</surname>
            <given-names>Kushagra</given-names>
          </name>
          <aff>Augusta University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>S&#x000e1;nchez-Manso</surname>
            <given-names>Juan Carlos</given-names>
          </name>
          <aff>Hospital Nuestra Se&#x000f1;ora del Rosario</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dmitri Aleksenko declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kushagra Maini declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Juan Carlos S&#x000e1;nchez-Manso declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24890.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Medication overuse headache (MOH) is thought to occur when medications intended to relieve headaches are consumed too frequently. Causal agents are varied and can include agents such as non-steroidal anti-inflammatory drugs, triptans, ergot derivatives, and opioids, although any analgesic can potentially trigger medication overuse headaches. This activity describes problems associated with the overuse of medications intended to relieve headaches and the evaluation and management of medication overuse headaches. This activity highlights the role of the interprofessional team in the management of headaches.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of medication overuse headaches.</p></list-item><list-item><p>Describe the pathophysiology of medication overuse headaches.</p></list-item><list-item><p>Explain the various options for managing medication overuse headaches.</p></list-item><list-item><p>Outline interprofessional team strategies for improving care coordination and communication to advance the prevention and management of medication overuse headaches and improve patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24890&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24890">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24890.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Medication overuse headache (MOH)&#x000a0;is thought to occur when medications intended to relieve&#x000a0;a headache are&#x000a0;consumed too frequently. This overuse causes a secondary type of headache. It was&#x000a0;formerly known as a rebound headache, and when it occurs in a person with a migraine, the overly frequent analgesic use "transforms" episodic suffering into a chronic one. The exact frequency of taking the pain-relieving&#x000a0;drug&#x000a0;before developing&#x000a0;medication overuse headache is variable and depends on the particular type of medication used. Causal agents include both simple and combination analgesics, such as NSAIDs, triptans, ergot derivatives, and opioids, but potentially any painkiller can be the trigger. Medication&#x000a0;overuse headache is common in patients at risk of overusing&#x000a0;acute medications. Anyone previously diagnosed with primary headache disorder is at risk for this condition, and the best characterized are those suffering from a migraine and tension-type headache.<xref ref-type="bibr" rid="article-24890.r1">[1]</xref><xref ref-type="bibr" rid="article-24890.r2">[2]</xref><xref ref-type="bibr" rid="article-24890.r3">[3]</xref></p>
        <p>According to the most recent ICHD-3b criteria, medication overuse headache is&#x000a0;described&#x000a0;as a headache occurring 15 or more days per month resulting from the overuse of acute headache medication for more than three months. Medication&#x000a0;overuse headache tends to resolve when the offending medication is limited.<xref ref-type="bibr" rid="article-24890.r4">[4]</xref><xref ref-type="bibr" rid="article-24890.r5">[5]</xref></p>
      </sec>
      <sec id="article-24890.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>For diagnosis of&#x000a0;medication overuse headache under the most recent ICHD-3b criteria, the following three points must be met:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>A headache must occur for 15 or more days per month in a patient with a previously diagnosed headache disorder.</p>
          </list-item>
          <list-item>
            <p>A patient must have misused the acute headache medication for over three months.</p>
          </list-item>
          <list-item>
            <p>A headache is not attributable to another ICHD-3 headache condition.</p>
          </list-item>
        </list>
        <p>Medication overuse headache is thought to occur when patients are taking acute headache medication with the following frequencies: 15 days or more per month for simple analgesics (i.e., acetaminophen, NSAIDs); and ten days or more per month for ergotamine, triptans, opioids,&#x000a0;or combination analgesics (i.e., butalbital/acetaminophen/caffeine).<xref ref-type="bibr" rid="article-24890.r6">[6]</xref><xref ref-type="bibr" rid="article-24890.r7">[7]</xref></p>
        <p>ICHD-3b states that when a combination of different headache medications is used, their combined frequency can lead to medication overuse headache, even when the individual drugs are not overused separately.</p>
        <p>Patients with headaches respond to acute medications differently. The use of an inappropriate headache abortive medication, or less effective medication, can&#x000a0;increase the frequency of medication consumption and lead to medication overuse headache. For example, given the differences in efficacy in treating migraines between&#x000a0;acetaminophen 1000 mg PO (NNT=12)&#x000a0;and ibuprofen 400 mg by mouth (NNT=&#x000a0;7.2), the patient using acetaminophen will generally end up requiring more frequent dosages&#x000a0;of&#x000a0;this&#x000a0;medication to control a headache compared to those who are using ibuprofen.</p>
      </sec>
      <sec id="article-24890.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Medication overuse headache is&#x000a0;considered&#x000a0;one of the more prevalent neurological disorders.&#x000a0;The 2015 Global Burden of Disease (GBD) study estimated its prevalence at 1% worldwide (approximately 58.5 million people), which is lower&#x000a0;compared to migraine and tension-type headaches. The&#x000a0;same GBD study included medication overuse headache among&#x000a0;the 20 most debilitating diseases.</p>
        <p>It&#x000a0;occurs fairly commonly in patients with chronic migraines (CM), with estimates of about 32% of patients&#x000a0;within the&#x000a0;chronic migraine&#x000a0;group having medication overuse headaches. Medication&#x000a0;overuse headache is believed to be more common in women (male&#x000a0;to female&#x000a0;ratio ranging from 2&#x000a0;to 1 to 5&#x000a0;to 1) and those with low socioeconomic&#x000a0;status.<xref ref-type="bibr" rid="article-24890.r8">[8]</xref></p>
      </sec>
      <sec id="article-24890.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The exact mechanism of medication overuse headache is unclear. It is hypothesized that medication overuse headache is attributed to the depletion of 5-HT&#x000a0;by overuse of headache abortive medications. This leads to&#x000a0;neuronal hyperexcitability in the cerebral cortex (which can lead to cortical spreading depression) and the trigeminal system (which produces&#x000a0;peripheral and central sensitization). The decrease in 5-HT levels leads to increased CGRP release from trigeminal ganglia, which is involved in the subsequent sensitization of nociceptive trigeminal neurons.</p>
        <p>Other studies demonstrate structural and functional brain changes&#x000a0;that occur in medication overuse headaches. There&#x000a0;are notable changes&#x000a0;in&#x000a0;metabolism in various brain structures as seen on PET scans of medication overuse headache patients. These&#x000a0;changes were mostly reversed upon withdrawal of analgesic&#x000a0;medication, except for persistent&#x000a0;hypometabolism seen in the orbitofrontal area. This particular&#x000a0;area is known to be involved in drug dependence and is hypothesized to be a risk factor for subsequent relapse&#x000a0;in analgesic&#x000a0;overuse and recurrent medication overuse headache.<xref ref-type="bibr" rid="article-24890.r9">[9]</xref></p>
      </sec>
      <sec id="article-24890.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinical presentation of medication overuse headache varies between patients and even changes with time in the same patient. There can&#x000a0;be an increase in the frequency of a pre-existing headache or the evolution into a new type of headache. There are no specific tests to diagnose this condition, and thus it is headache quantity and frequency, and type and frequency of acute medication used&#x000a0;that leads to the diagnosis.<xref ref-type="bibr" rid="article-24890.r10">[10]</xref> Although pain location and quality are non-specific in medication overuse headache, there are some general&#x000a0;features commonly seen&#x000a0;in this patient population; these include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>The&#x000a0;headaches are usually&#x000a0;episodic</p>
          </list-item>
          <list-item>
            <p>Frequent acute medication consumption depends on the type of abortive&#x000a0;medication used (see Etiology section for more detail)</p>
          </list-item>
          <list-item>
            <p>Neck pain is common (often mistaken for a cervicogenic headache, which in turn&#x000a0;tends to be resistant to cervicalgia-appropriate treatments)</p>
          </list-item>
          <list-item>
            <p>Typically occurs in the morning (presumed&#x000a0;related to withdrawal occurring during sleep)</p>
          </list-item>
          <list-item>
            <p>Poor sleep</p>
          </list-item>
          <list-item>
            <p>Autonomic symptoms (i.e., nasal congestion, rhinorrhea, gastrointestinal [GI] disturbance) are more frequent with overused opioids</p>
          </list-item>
          <list-item>
            <p>Comorbid anxiety and depression</p>
          </list-item>
          <list-item>
            <p>All headache treatments are generally less effective when medication overuse headache is present; efficacy improves after the weaning.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24890.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>There are currently no specific biomarkers or studies whereby differentiate or point towards medication overuse headache. The diagnosis is purely clinical and deserves special attention, not to be overlooked due to the potential consequences of worsening over time.</p>
      </sec>
      <sec id="article-24890.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Typical treatment involves weaning the patient off the overused acute headache medication while simultaneously&#x000a0;focusing on preventative&#x000a0;treatment. Several studies show that complete 100% weaning of overused acute medication shows the best results compared to&#x000a0;continuing on the same acute medication responsible for medication overuse headache but placing frequency limits on its use. Note that patients can be prescribed&#x000a0;a new acute medication from a different class. Patients can wean from the&#x000a0;offending medication abruptly ("cold turkey") or gradually over several weeks. Preventative treatment&#x000a0;can include prophylactic&#x000a0;medication&#x000a0;and/or non-pharmaceutical treatments (i.e., cognitive behavioral therapy,&#x000a0;biofeedback, relaxation training, lifestyle modification with trigger avoidance).<xref ref-type="bibr" rid="article-24890.r11">[11]</xref><xref ref-type="bibr" rid="article-24890.r12">[12]</xref><xref ref-type="bibr" rid="article-24890.r13">[13]</xref></p>
        <p>Educating the patient and their family on the importance of limiting acute medication&#x000a0;use is vital in preventing medication overuse headaches. Initial worsening of a headache within the first few days of weaning is relatively common.&#x000a0;Withdrawal symptoms&#x000a0;are&#x000a0;thought to typically last up to 10 days, then eventually followed by improvement in medication overuse headache. Weaning patients off medication overuse headache-related&#x000a0;medication can be done in an outpatient or an inpatient setting. Most cases can be managed&#x000a0;in the outpatient setting mainly through educating patients&#x000a0;to cut down on their acute medication use. It is important to address and treat co-morbid psychiatric conditions, especially anxiety and depression, which are often associated with medication overuse headaches, but without potentiating the boosting effects, anxiolytic medication has in maintaining the headache.</p>
        <p>Following successful weaning, about half of&#x000a0;patients relapse after five years; thus, it is essential to have the patient follow-up&#x000a0;regularly. Once the patient's medication overuse headache has resolved, tapering them off the preventative medication may be considered. There are no specific guidelines, but some professionals suggest tapering prophylactic medication after one year.<xref ref-type="bibr" rid="article-24890.r14">[14]</xref><xref ref-type="bibr" rid="article-24890.r15">[15]</xref></p>
      </sec>
      <sec id="article-24890.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Medication overuse headache occurs in patients with an episodic primary headache; thus, chronic versions of an episodic headache are one of the main differentials. Other secondary headaches must be ruled out with the guidance of the patient's clinical picture and the aid of all the necessary tests, more so when the features of the original episodic headache are different from its chronic counterpart.<xref ref-type="bibr" rid="article-24890.r16">[16]</xref><xref ref-type="bibr" rid="article-24890.r17">[17]</xref></p>
      </sec>
      <sec id="article-24890.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The results of a tailored regime are excellent in the long-term, but with an estimated relapse rate of about 30% within&#x000a0;six&#x000a0;months and 50%&#x000a0;following a 5-year period.<xref ref-type="bibr" rid="article-24890.r18">[18]</xref></p>
      </sec>
      <sec id="article-24890.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications&#x000a0;that may accompany&#x000a0;medication overuse headaches are symptomatic. These include nausea, anxiety, irritability, asthenia, restlessness, difficulty concentrating, problems with memory, and depression.<xref ref-type="bibr" rid="article-24890.r19">[19]</xref></p>
      </sec>
      <sec id="article-24890.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need to understand the etiology of their headaches&#x000a0;to comply with medication regimen changes; they will almost always need to restrict their medication use.&#x000a0;Depending on the drug used, patients may need to be told to stop their medication&#x000a0;immediately or gradually reduce the dose.</p>
      </sec>
      <sec id="article-24890.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Practitioners contend that frequent use of acute headache medications&#x000a0;may reflect poorly controlled headaches and not necessarily the cause. This idea stems from evidence&#x000a0;that&#x000a0;not all patients improve&#x000a0;when they stop taking headache-relieving medications.&#x000a0;Instead of primarily blaming analgesic medication overuse as the reason for the increase in headache frequency, clinicians must be cautious in managing these patients and not overlook those in whom headaches are simply poorly controlled. Some studies suggested that other substances, such as the regular use of tranquilizers or other recreational substances abused in the general population, should be&#x000a0;considered in conjunction with analgesics.</p>
      </sec>
      <sec id="article-24890.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of medication overuse headaches are complex and best done with an interprofessional team that includes clinicians (MDs, DOs, NPs, and PAs), possibly specialists, nursing staff, and pharmacists. Educating the patient and family&#x000a0;on the importance of limiting acute medication&#x000a0;use is vital in preventing medication overuse headaches. The underlying psychiatric condition must be addressed, and a referral to a mental health professional can be helpful. All interprofessional team members are responsible for contributing from their areas of expertise, documenting any change in patient status, and communicating their observations with other team members as appropriate so therapeutic interventions can occur if necessary.</p>
        <p>Following successful weaning, about half of&#x000a0;patients relapse after five years; thus, it is essential to have the patient follow-up&#x000a0;regularly. Once the patient's medication overuse headaches have resolved, tapering them off the preventative medication may be considered. There are no specific guidelines, but some professionals suggest tapering prophylactic medication after one year.&#x000a0;</p>
      </sec>
      <sec id="article-24890.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24890&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24890">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/migraine-headaches/headache-from-medication-overuse/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24890">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24890/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24890">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24890.s16">
        <title>References</title>
        <ref id="article-24890.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Limmer</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Loftus</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Zonisamide for Cluster Headache Prophylaxis: A Case Series.</article-title>
            <source>Headache</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>924</fpage>
            <page-range>924-929</page-range>
            <pub-id pub-id-type="pmid">31038740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mose</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Gram</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Personality traits in migraine and medication-overuse headache: A comparative study.</article-title>
            <source>Acta Neurol Scand</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>140</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-122</page-range>
            <pub-id pub-id-type="pmid">31038726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Young</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Philpot</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Vierkant</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Rosedahl</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Upadhyaya</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ebbert</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Episodic and Chronic Migraine in Primary Care.</article-title>
            <source>Headache</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>59</volume>
            <issue>7</issue>
            <fpage>1042</fpage>
            <page-range>1042-1051</page-range>
            <pub-id pub-id-type="pmid">31032913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandoe</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lay</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Secondary Headaches During Pregnancy: When to Worry.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2019</year>
            <month>Apr</month>
            <day>22</day>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>27</fpage>
            <pub-id pub-id-type="pmid">31011857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Micieli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kingston</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>An Approach to Identifying Headache Patients That Require Neuroimaging.</article-title>
            <source>Front Public Health</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>52</fpage>
            <pub-id pub-id-type="pmid">30931292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grazzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Chronic migraine and medication overuse: which strategy for a complex scenario.</article-title>
            <source>Neurol Sci</source>
            <year>2019</year>
            <month>May</month>
            <volume>40</volume>
            <issue>Suppl 1</issue>
            <fpage>175</fpage>
            <page-range>175-176</page-range>
            <pub-id pub-id-type="pmid">30906961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turner</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Lebowitz</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Chtay</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Houle</surname>
                <given-names>TT</given-names>
              </name>
            </person-group>
            <article-title>Headache Triggers as Surprise.</article-title>
            <source>Headache</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>495</fpage>
            <page-range>495-508</page-range>
            <pub-id pub-id-type="pmid">30919414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kulkarni</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mailankody</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Medication Overuse Headache.</article-title>
            <source>Neurol India</source>
            <year>2021</year>
            <season>Mar-Apr</season>
            <volume>69</volume>
            <issue>Supplement</issue>
            <fpage>S76</fpage>
            <page-range>S76-S82</page-range>
            <pub-id pub-id-type="pmid">34003151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dripps</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Bertels</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Moye</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Tipton</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Siegersma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Baca</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kieffer</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Pradhan</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.</article-title>
            <source>Sci Rep</source>
            <year>2020</year>
            <month>Oct</month>
            <day>19</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>17629</fpage>
            <pub-id pub-id-type="pmid">33077757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scher</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Rizzoli</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Loder</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Medication overuse headache: An entrenched idea in need of scrutiny.</article-title>
            <source>Neurology</source>
            <year>2017</year>
            <month>Sep</month>
            <day>19</day>
            <volume>89</volume>
            <issue>12</issue>
            <fpage>1296</fpage>
            <page-range>1296-1304</page-range>
            <pub-id pub-id-type="pmid">28821684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferini-Strambi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Galbiati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Combi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Sleep disorder-related headaches.</article-title>
            <source>Neurol Sci</source>
            <year>2019</year>
            <month>May</month>
            <volume>40</volume>
            <issue>Suppl 1</issue>
            <fpage>107</fpage>
            <page-range>107-113</page-range>
            <pub-id pub-id-type="pmid">30906963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barmherzig</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kingston</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <day>19</day>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>20</fpage>
            <pub-id pub-id-type="pmid">30888540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russell</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and management of medication-overuse headache in the general population.</article-title>
            <source>Neurol Sci</source>
            <year>2019</year>
            <month>May</month>
            <volume>40</volume>
            <issue>Suppl 1</issue>
            <fpage>23</fpage>
            <page-range>23-26</page-range>
            <pub-id pub-id-type="pmid">30887240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arca</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Halker Singh</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>The Hypertensive Headache: a Review.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <day>14</day>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>30</fpage>
            <pub-id pub-id-type="pmid">30874912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bottiroli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Galli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Viana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Icco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bitetto</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Allena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pazzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sances</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tassorelli</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Negative Short-Term Outcome of Detoxification Therapy in Chronic Migraine With Medication Overuse Headache: Role for Early Life Traumatic Experiences and Recent Stressful Events.</article-title>
            <source>Front Neurol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>173</fpage>
            <pub-id pub-id-type="pmid">30899242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saengjaroentham</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strother</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Dripps</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sultan Jabir</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Pradhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Differential medication overuse risk of novel anti-migraine therapeutics.</article-title>
            <source>Brain</source>
            <year>2020</year>
            <month>Sep</month>
            <day>01</day>
            <volume>143</volume>
            <issue>9</issue>
            <fpage>2681</fpage>
            <page-range>2681-2688</page-range>
            <pub-id pub-id-type="pmid">32810212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Diener</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>The dependence scale: an easy tool to detect chronic daily headache with medication overuse?</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>80</volume>
            <issue>7</issue>
            <fpage>704</fpage>
            <pub-id pub-id-type="pmid">19531683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munksgaard</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Madsen</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Wienecke</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Treatment of medication overuse headache-A review.</article-title>
            <source>Acta Neurol Scand</source>
            <year>2019</year>
            <month>May</month>
            <volume>139</volume>
            <issue>5</issue>
            <fpage>405</fpage>
            <page-range>405-414</page-range>
            <pub-id pub-id-type="pmid">30710346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24890.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dodick</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Freitag</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Evidence-based understanding of medication-overuse headache: clinical implications.</article-title>
            <source>Headache</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>46 Suppl 4</volume>
            <fpage>S202</fpage>
            <page-range>S202-11</page-range>
            <pub-id pub-id-type="pmid">17078852</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
